Washington University in St. Louis
Mission Statement
At a Glance
2
Educational Resources Posted
62
Consortium News Stories Posted
1
Events Posted
0
Opportunities Posted
86
Publications citing CTSA Program Grant
27
Users from Hub Registered
UL1 Award
KL2 Award
TL1 Award
UL1
UL1 Director
UL1 Administrator
Education
KL2 Administrator
TL1 Director
TL1 Administrator
Communications
Communications Representative
Enterprise Committees
Integration Across Lifespan Voting Member
Common Metrics
Primary CM Contact
Additional CM Contacts
PhilipPayneRobert J. Terry Professor and Director, Institute for Informatics (I2)
PhilipPayneAssociate Dean for Health information and Data Science / Chief Data Scientist, Washington University School of Medicine
SusanStarkAssociate Professor of Occupational Therapy, Neurology and Social Work
SureshVedanthamAssistant Dean for Clinical Research, Professor of Radiology & Surgery
Consortium News
Washington University ICTS supported research shows that rapid saliva test screenings – aimed at early detection of the virus – contributed to exceedingly low transmission of the virus among students, teachers and staff in the six schools overseen by the Special School District of St. Louis County, the largest specialized education provider in Missouri.
Nearly 90% of people taking immunosuppressants to treat autoimmune conditions produce an antibody response to COVID-19 vaccination, but the response is weaker than those generated by healthy people, according to a study by ICTS researchers at Washington University School of Medicine.
NIH Director, Francis Collins, MD, features ICTS research in his August 24th blog post, “The Amazing Brain: Tracking Molecular Events with Calling Cards”
Educational Content
Washington University in St. Louis is recruiting for the fall program of our NIH-funded Entrepreneurship for Biomedicine (E4B) training program. E4B is free and taught fully online through Washington University in St. Louis. As an E4B trainee, you will work with biomedical research trainees from across the nation to innovatively solve problems in these challenging times, and develop skills in
Events
Poster Sessions
As a result of the CTSA Program’s objective to strengthen multidisciplinary research infrastructure, hubs are uniquely poised to mobilize their vast resources to produce a rapid, nimble, multi-faceted approach to national public health emergencies. The Institute of Clinical and Translational Sciences, the CTSA grantee at Washington University in St. Louis, is a critical contributor to the
The goal of the Precision Medicine function of the Washington University Institute of Clinical and Translational Sciences is to streamline precision medicine research processes across the university. Three separate initiatives supported this effort: (1) outreach to community and faculty members through surveys and focus groups to assess interest and concerns regarding participation in precision
Publications
Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer
Triple-negative breast cancer (TNBC) is the deadliest form of breast cancer. Unlike other types of breast cancer that can be effectively treated by targeted therapies, no such targeted therapy exists for all TNBC patients. The ADAR1 enzyme carries out A-to-I editing of RNA to prevent sensing of
Eating disorder symptomatology, clinical impairment, and comorbid psychopathology in racially and ethnically diverse college women with eating disorders
To examine eating disorder (ED) symptomatology, related clinical impairment, and comorbid psychopathology in college women with EDs across five racial and two ethnic groups. Participants were 690 women from 28 US universities who screened positive for an ED. Thirteen variables assessing ED symptoms
The safety of hepatectomy after transarterial radioembolization: Single institution experience and review of the literature
The liver is a frequent site of malignancy, both primary and metastatic. The treatment goal of patients with liver cancer may include transarterial radioembolization (TARE). There are limited reports on the safety of hepatectomy following TARE. Our study's purpose is to review patients who have
Research and Operational Tools
The Translational Science Benefits Model (TSBM) is a framework designed to support institutional assessment of clinical and translational research outcomes to measure clinical and community health impacts beyond bibliometric measures.